Castle Biosciences (NasdaqGM:CSTL) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Company ParticipantsCamilla Zuckero - Vice President, Investor Relations and Corporate AffairsCarlos Peniche - Former Equity Research AssociateDerek Maetzold - Founder, President, and CEOFrank Stokes - CFOThomas Heinzen - Managing Director in Healthcare Investment BankingConference Call ParticipantsAlex Vukasin - Healthcare Equity Research AnalystJosh R. Waldman - Equity Research AnalystMason Carrico - Research AnalystMat ...

BioLife Solutions (NasdaqCM:BLFS) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Company ParticipantsAnna Snopkowski - Equity Research AssociateRoderick de Greef - Chairman and CEOTroy Wichterman - CFOConference Call ParticipantsBrendan Smith - Director, Life Science & Diagnostic Tools and Biotech AnalystCarl Byrnes - Managing Director, Senior Research AnalystMacae Etoch - Equity Research AnalystMatt Hewett - Senior Research AnalystMatt Stanton - Equity Research AnalystMichael Okunewitch - Senior Resea ...

Castle Biosciences (NasdaqGM:CSTL) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Company ParticipantsCamilla Zuckero - Vice President, Investor Relations and Corporate AffairsCarlos Peniche - Former Equity Research AssociateDerek Maetzold - Founder, President, and CEOFrank Stokes - CFOThomas Heinzen - Managing Director in Healthcare Investment BankingConference Call ParticipantsAlex Vukasin - Healthcare Equity Research AnalystJosh R. Waldman - Equity Research AnalystMason Carrico - Research AnalystMat ...

Caris Life Sciences (NasdaqGS:CAI) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Company ParticipantsBobby Hill - CCOBrian Brille - Vice Chairman and EVPColleen Babington - Equity Research AssociateDavid Spetzler - PresidentLuke Power - CFOMichael Ryskin - Managing DirectorPatrick Donnelly - Managing Director, Equity ResearchRuss Denton - General CounselSubbu Nambi - Managing Director and Healthcare Equity ResearchVijay Kumar - Senior Managing DirectorConference Call ParticipantsDaniel Brennan - Senio ...

OPKO Health (NasdaqGS:OPK) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Company ParticipantsAdam Logal - SVP and CFOElias Zerhouni - Vice Chairman and PresidentGary Nabel - CIOPhillip Frost - Chairman and CEOYvonne Briggs - Director of Investor RelationsNone - Company RepresentativeNone - Company RepresentativeConference Call ParticipantsBrian Cheng - Executive Director and Senior Biotech AnalystEdward Tenthoff - Managing Director and Senior Research AnalystYale Jen - Senior Biotech AnalystOperatorHe ...

BioLife Solutions (NasdaqCM:BLFS) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Company ParticipantsAnna Snopkowski - Equity Research AssociateRoderick de Greef - Chairman and CEOTroy Wichterman - CFOConference Call ParticipantsBrendan Smith - Director, Life Science & Diagnostic Tools and Biotech AnalystCarl Byrnes - Managing Director, Senior Research AnalystMacason Etok - Equity Research AnalystMatt Hewitt - Senior Research AnalystMatt Stanton - Equity Research AnalystMichael Okunewitch - Senior Rese ...

Crinetics Pharmaceuticals (NasdaqGS:CRNX) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Company ParticipantsAlan Krasner - Chief EndocrinologistCatherine Novack - Director of Healthcare Equity ResearchGayathri Diwakar - Head of Investor RelationsIsabel Kalofonos - Chief Commercial OfficerScott Struthers - Founder and CEOToby Schilke - CFOConference Call ParticipantsAlex Thompson - Senior Equity Research AnalystAndy Chen - Director and Senior Equity Research AnalystDennis Ding - VP and Equity Research ...

Puma Biotechnology (NasdaqGS:PBYI) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Speaker4Good morning. Oh, good afternoon, ladies and gentlemen. My name is Sherry, and I will be your conference call operator today. At this time, all participants are in a listen-only mode. After the speaker's formal remarks, there will be a question-and-answer session. If you would like to ask a question during that time, simply press the star key, then the number one on your telephone keypad. If you would like to with ...

FINANCIAL RESULTS: Q4:2025 and Full Year 2025 SLIDE SUPPLEMENT NASDAQ: TKNO February 26, 2026 Forward-looking statements and use of non-GAAP financial measures This meeting is for the purpose of familiarizing you with Alpha Teknova, Inc. ("Teknova") and is made for informational purposes only and nothing in the presentation should be viewed, or construed, as "advice". You understand and agree that the fact this meeting has taken place and anything you hear or learn during this meeting is strictly confidenti ...

Caris Life Sciences (NasdaqGS:CAI) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Speaker9Everyone, and welcome to the Caris Life Sciences Q4 2025 earnings call. My name is Dana, and I will be your coordinator today. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star one one on your telephone. You will then hear an automated message advising that your han ...